Nitinol grips prevent slips in Abbott’s heart valve clips

Nitinol is a key material in the heart valve clips that Abbott designed for its TriClip and MitraClip transcatheter edge-to-edge repair (TEER) systems.

How Abbott created its next-gen RF ablation system

Pulsed field ablation (PFA) has generated a great deal of buzz for its potential to reduce complications in procedures for treating atrial fibrillation (AFib). But even as Abbott is developing its Volt PFA system — announcing in January that it kicked off a CE mark clinical trial of Volt — the medtech giant is betting that tried-and-true radiofrequency (RF) ablation can still make a big difference with the right innovations.

BD Increases US Syringe Production After FDA Warnings on China-Made Syringes

Becton, Dickinson and Company (BD) has announced its intention to increase US production of syringes after FDA recently reported that its ongoing investigation into quality issues with plastic syringes made in China were “more widespread” than originally known.

Medtronic Muses on Diabetes Management Technologies

Axena Study Underscores Incontinence Burden for Women in Sub-Saharan Africa

Axena Health, a medical technology company focused on female pelvic health, has unveiled the findings of its landmark study to understand the far-reaching impacts of urinary incontinence (UI) on women in sub-Saharan Africa.

Boston Sci Nabs FDA Approval for Agent DCB

Boston Scientific today announced FDA approval of its Agent drug-coated balloon (DCB), making it the first coronary DCB indicated for in-stent restenosis (ISR) in patients with coronary artery disease in the United States.

Philips Recalls MRI System Due to a Risk of Explosion

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.

Getinge Purchases Healthmark Industries for $320 Million

The acquisition aims to bolster Getinge’s U.S. sterile reprocessing business.

Medtronic and Axonics Back for Final Showdown

The U.S. Patent Trial and Appeal Board made a mistake in Medtronic’s favor last year, a federal judge ruled this week.

Are Things Starting to Turn Around for Philips?

For the most part, the story of Philips has been consistent since 2021 and unfortunately, the narrative has been one of recalls and massive dips in shares. However, that story changed a bit today, when the Amsterdam-based company raised its 2023 outlook after beating consensus in the second quarter.